Innovent and Lilly Expand Strategic Partnership in Oncology


Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company (“Lilly”,NYSE: LLY) today announced that in light of both parties’ shared commitment to continue bringing innovative medicines to benefit Chinese patients and to leverage the strengths of each party in a win-win manner, parties will now expand the strategic partnership through

Read More

Next Post

Medical Revolution: AI Firm WEIYUN AI & Robotics Group Launches Orthodontic Smart Alignment System Venus 1.0

Recently, the leading surgical robotic and AI customerized industrial Internet company – Weiyun AI&Robotics Group has successfully developed AI SMILE Orthodontic Smart Alignment System named Venus 1.0, which Intellisense, analysis, generate and demonstrate the personalized dynamic treatment process in 1 minute. Based on its pioneering technology of artificial intelligence, biomechanics […]